유도객담검사를 통해 분류된 저과립구 천식 환자군의 임상 양상 및 의의
Clinical features of patients with paucigranulocytic asthma classified based on the induced sputum test
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Asthma phenotypes are often defined by relative cell counts of airway granulocytes. Induced sputum test results enable clinicians to determine the inflammatory phenotype of asthma based on the eosinophil and neutrophil counts. This study aimed to investigate clinical characteristics of patients with asthma according to the inflammatory phenotype of their condition. Methods: Data from 107 patients with asthma reported at a single tertiary allergy center in Korea during October 2016 to January 2019 were obtained. Patients were categorized into 4 asthma phenotypes based on the cell counts on the induced sputum test: eosinophilic, neutrophilic, mixed, and paucigranulocytic types. Blood eosinophil count, total IgE level, eosinophil cationic protein, spirometric measurements, fractional exhaled nitric oxide, atopy based on the skin prick test, PC20 (provocative concentration of methacholine causing a 20% fall in forced expiratory volume in 1 second) in methacholine provocation test, type of asthma controller used, frequency of exacerbation, and use of systemic corticosteroids were examined. Results: The frequency of phenotype is as follows: eosinophilic (21.4%), neutrophilic (34.8%), mixed (13.4%), and paucigranulocytic types (30.4%). During the observation period, the proportion of patients who experienced an exacerbation and received systemic glucocorticosteroids were significantly lower in patients with the paucigranulocytic type of asthma than in those with the mixed type of asthma (6.3% vs. 40.0%; P=0.007 and 5.9% vs. 40.0%; P=0.004, respectively). Conclusion: Paucigranulocytic asthma may be associated with lower incidence rates of asthma exacerbation and systemic corticosteroid use than the other phenotypes, classified according to induced sputum test results.
Abstract
Purpose: Asthma phenotypes are often defined by relative cell counts of airway granulocytes. Induced sputum test results enable clinicians to determine the inflammatory phenotype of asthma based on the eosinophil and neutrophil counts. This study aimed to investigate clinical characteristics of patients with asthma according to the inflammatory phenotype of their condition. Methods: Data from 107 patients with asthma reported at a single tertiary allergy center in Korea during October 2016 to January 2019 were obtained. Patients were categorized into 4 asthma phenotypes based on the cell counts on the induced sputum test: eosinophilic, neutrophilic, mixed, and paucigranulocytic types. Blood eosinophil count, total IgE level, eosinophil cationic protein, spirometric measurements, fractional exhaled nitric oxide, atopy based on the skin prick test, PC20 (provocative concentration of methacholine causing a 20% fall in forced expiratory volume in 1 second) in methacholine provocation test, type of asthma controller used, frequency of exacerbation, and use of systemic corticosteroids were examined. Results: The frequency of phenotype is as follows: eosinophilic (21.4%), neutrophilic (34.8%), mixed (13.4%), and paucigranulocytic types (30.4%). During the observation period, the proportion of patients who experienced an exacerbation and received systemic glucocorticosteroids were significantly lower in patients with the paucigranulocytic type of asthma than in those with the mixed type of asthma (6.3% vs. 40.0%; P=0.007 and 5.9% vs. 40.0%; P=0.004, respectively). Conclusion: Paucigranulocytic asthma may be associated with lower incidence rates of asthma exacerbation and systemic corticosteroid use than the other phenotypes, classified according to induced sputum test results.
참고문헌 (40)
- Papi A, "Asthma", Lancet, 391, pp.783~800 (2018)
- Moore WC, "Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program", Am J Respir Crit Care Med, 181, pp.315~323 (2010)
- Carr TF, "Eosinophilic and noneosinophilic asthma", Am J Respir Crit Care Med, 197, pp.22~37 (2018)
- Tliba O, "Paucigranulocytic asthma : uncoupling of airway obstruction from inflammation", J Allergy Clin Immunol, 143, pp.1287~1294 (2019)
- Balzar S, "Transbronchial biopsy as a tool to evaluate small airways in asthma", Eur Respir J, 20, pp.254~259 (2002)
- Nocker RE, "Induced sputum and bronchoalveolar lavage as tools for evaluating the effects of inhaled corticosteroids in patients with asthma", J Lab Clin Med, 136, pp.39~49 (2000)
- Kips JC, "Methods for sputum induction and analysis of induced sputum : a method for assessing airway inflammation in asthma", Eur Respir J Suppl, 26, pp.9~12 (1998)
- al-Ali MK, "Nitric oxide and the respiratory system in health and disease", Respir Med, 92, pp.701~715 (1998)
- 김민혜, "유도객담검사의 시행과 해석: 전문가 의견서", Allergy Asthma & Respiratory Disease, 5(6), pp.307~311 (2017), 대한 소아알레르기 호흡기학회[DOI]
- Ntontsi P, "Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma : comparison with different sputum phenotypes", Allergy, 72, pp.1761~1767 (2017)
- Kim MY, "Reference ranges for induced sputum eosinophil counts in Korean adult population", Asia Pac Allergy, 4, pp.149~155 (2014)
- Yancey SW, "Biomarkers for severe eosinophilic asthma", J Allergy Clin Immunol, 140, pp.1509~1518 (2017)
- Seys SF, "Role of sputum biomarkers in the management of asthma", Curr Opin Pulm Med, 23, pp.34~40 (2017)
- Castro M, "Reslizumab for poorly controlled, eosinophilic asthma : a randomized, placebo-controlled study", Am J Respir Crit Care Med, 184, pp.1125~1132 (2011)
- Ray A, "Neutrophilic inflammation in asthma and association with disease severity", Trends Immunol, 38, pp.942~954 (2017)
- Berry M, "Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma", Thorax, 62, pp.1043~1049 (2007)
- Green RH, "Analysis of induced sputum in adults with asthma : identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids", Thorax, 57, pp.875~879 (2002)
- Wark PA, "Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma", Eur Respir J, 19, pp.68~75 (2002)
- Reddel HK, "Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes", J Allergy Clin Immunol Pract, 10(1S), pp.S1~S18 (2022)
- 서미혜, "Prevalence of Obesity and Incidence of Obesity-Related Comorbidities in Koreans Based on National Health Insurance Service Health Checkup Data 2006-2015 (J Obes Metab Syndr 2018;27:46-52)", Journal of Obesity & Metabolic Syndrome, 27(3), pp.198~199 (2018), 대한비만학회
- Roufosse F, "Practical approach to the patient with hypereosinophilia", J Allergy Clin Immunol, 126, pp.39~44 (2010)
- Heinzerling L, "The skin prick test-European standards", Clin Transl Allergy, 3, pp.3~ (2013)
- Nelson HS, "Effect of distance between sites and region of the body on results of skin prick tests", J Allergy Clin Immunol, 97, pp.596~601 (1996)
- 임경환, "기관지유발검사 시행과 해석: 전문가 의견서", Allergy Asthma & Respiratory Disease, 6(1), pp.14~25 (2018), 대한 소아알레르기 호흡기학회[DOI]
- Crapo RO, "Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999", Am J Respir Crit Care Med, 161, pp.309~329 (2000)
- American Thoracic Society, "ATS", ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005, 2005, pp.171, 912~930
- 심다운, "성인 천식의 바이오마커와 맞춤의학", Allergy Asthma & Respiratory Disease, 4(1), pp.4~13 (2016), 대한 소아알레르기 호흡기학회[DOI]
- Schoettler N, "Recent advances in severe asthma : from phenotypes to personalized medicine", Chest, 157, pp.516~528 (2020)
- Haldar P, "Noneosinophilic asthma : a distinct clinical and pathologic phenotype", J Allergy Clin Immunol, 119, pp.1043~1052 (2007)
- Jung JW, "Clinical characteristics and long-term outcomes related to sputum eosinophilia in Korean asthmatics", Asia Pac Allergy, 1, pp.16~24 (2011)
- 박배균, "소아 천식 및 호산구성기관지염에서 유도객담 호산구분율과 혈청 및 혈액 알레르기 지표와 연관성", Allergy Asthma & Respiratory Disease, 8(4), pp.220~226 (2020), 대한 소아알레르기 호흡기학회[DOI]
- 장안수, "Impact of Atopy on Asthma and Allergic Rhinitis in the Cohort for Reality and Evolution of Adult Asthma in Korea", Allergy, Asthma & Immunology Research, 5(3), pp.143~149 (2013), 대한천식알레르기학회
- Gyu-Young Hur, "Serum potential biomarkers according to sputum inflammatory cell profiles in adult asthmatics", The Korean Journal of Internal Medicine, 35(4), pp.988~997 (2020), 대한내과학회[DOI]
- Wang F, "Different inflammatory phenotypes in adults and children with acute asthma", Eur Respir J, 38, pp.567~574 (2011)
- 윤호주, "Intermittent to Mild Asthma: The Need for Continued Treatment", Allergy, Asthma & Immunology Research, 5(6), pp.341~342 (2013), 대한천식알레르기학회
- Panettieri RA Jr, "Neutrophilic and pauci-immune phenotypes in severe asthma", Immunol Allergy Clin North Am, 36, pp.569~579 (2016)
- Wenzel S, "Severe asthma in adults", Am J Respir Crit Care Med, 172, pp.149~160 (2005)
- Hastie AT, "Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects", J Allergy Clin Immunol, 132, pp.72~80 (2013)
- Simpson JL, "Inflammatory subtypes in asthma : assessment and identification using induced sputum", Respirology, 11, pp.54~61 (2006)
- Reddel HK, "An official American Thoracic Society", European Respiratory Society statement : asthma control and exacerbations : standardizing endpoints for clinical asthma trials and clinical practice, 2009, pp.180, 59~99